Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Apr 30, 2025 | (FY)Oct 31, 2024 | (Q6)Apr 30, 2024 | (FY)Oct 31, 2023 | (Q6)Apr 30, 2023 | (FY)Oct 31, 2022 | (Q6)Apr 30, 2022 | (FY)Oct 31, 2021 | (Q6)Apr 30, 2021 | (FY)Oct 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -106.54%-559K | ---- | 29.01%8.54M | ---- | -14.70%6.62M | ---- | -11.74%7.76M | ---- | 203.31%8.8M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 67.47%-256K | ---- | -137.76%-787K | ---- | 34.71%-331K | ---- | 47.41%-507K | ---- | -215.03%-964K |
| Interest expense - adjustment | ---- | -9.96%886K | ---- | 20.59%984K | ---- | 24.01%816K | ---- | -8.23%658K | ---- | 40.31%717K |
| Attributable subsidiary (profit) loss | ---- | -207.81%-197K | ---- | 76.21%-64K | ---- | -17.98%-269K | ---- | 15.56%-228K | ---- | -178.35%-270K |
| Impairment and provisions: | ---- | 96.60%1.27M | ---- | 145.08%647K | ---- | 131.17%264K | ---- | 71.99%-847K | ---- | -717.30%-3.02M |
| -Impairmen of inventory (reversal) | ---- | -437.41%-911K | ---- | -19.64%270K | ---- | 155.17%336K | ---- | -1.16%-609K | ---- | -71.02%-602K |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | 52.32%-72K | ---- | -125.99%-151K | ---- | 11,720.00%581K |
| -Other impairments and provisions | ---- | 479.05%2.18M | ---- | --377K | ---- | ---- | ---- | 97.10%-87K | ---- | -23,000.00%-3M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 385.00%171K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 385.00%171K |
| Depreciation and amortization: | ---- | -5.79%6.35M | ---- | 23.33%6.74M | ---- | -22.75%5.46M | ---- | 9.78%7.07M | ---- | 57.39%6.44M |
| Exchange Loss (gain) | ---- | ---- | ---- | 22.56%326K | ---- | 106.20%266K | ---- | -27.12%129K | ---- | 80.61%177K |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---56K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -54.28%7.49M | ---- | 27.71%16.38M | ---- | -8.24%12.83M | ---- | 16.10%13.98M | ---- | 77.95%12.04M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 309.14%1.53M | ---- | 71.31%-733K | ---- | -187.71%-2.56M | ---- | 3,072.45%2.91M | ---- | -101.96%-98K |
| Accounts receivable (increase)decrease | ---- | -3.54%-8.28M | ---- | -355.63%-8M | ---- | 36.36%3.13M | ---- | 127.60%2.29M | ---- | -2,889.57%-8.31M |
| Accounts payable increase (decrease) | ---- | 96.71%-163K | ---- | 69.65%-4.96M | ---- | -94.39%-16.34M | ---- | 22.14%-8.4M | ---- | -135.36%-10.79M |
| prepayments (increase)decrease | ---- | -286.06%-6.87M | ---- | 18.69%-1.78M | ---- | -164.33%-2.19M | ---- | 169.14%3.4M | ---- | -717.11%-4.92M |
| Special items for working capital changes | ---- | -47.31%753K | ---- | 180.64%1.43M | ---- | -148.17%-1.77M | ---- | 453.75%3.68M | ---- | -129.92%-1.04M |
| Cash from business operations | ---- | -335.65%-5.53M | ---- | 134.06%2.35M | ---- | -138.58%-6.89M | ---- | 236.18%17.87M | ---- | -129.23%-13.12M |
| Other taxs | ---- | -106.25%-4.06M | ---- | 29.32%-1.97M | ---- | 71.82%-2.78M | ---- | -145.06%-9.88M | ---- | -2,953.03%-4.03M |
| Special items of business | 146.63%1.72M | ---- | -47.97%-3.69M | ---- | 65.65%-2.49M | ---- | -2.24%-7.26M | ---- | 84.49%-7.1M | ---- |
| Net cash from operations | 146.63%1.72M | -2,617.06%-9.59M | -47.97%-3.69M | 103.94%381K | 65.65%-2.49M | -221.12%-9.68M | -2.24%-7.26M | 146.59%7.99M | 84.49%-7.1M | -138.32%-17.15M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -67.47%256K | ---- | 137.76%787K | ---- | -34.84%331K | ---- | -47.30%508K | ---- | 215.03%964K |
| Decrease in deposits (increase) | ---- | ---- | ---- | --9.02M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | -93.46%191K | ---- | --2.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | 56.09%-2.78M | ---- | 12.76%-6.33M | ---- | -32.51%-7.26M | ---- | -325.64%-5.48M | ---- | 11.79%-1.29M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.1M |
| Other items in the investment business | 97.45%-32K | ---- | -116.48%-1.26M | ---- | 588.64%7.61M | ---- | -59.63%-1.56M | ---- | -165.33%-976K | ---- |
| Net cash from investment operations | 97.45%-32K | -136.50%-2.33M | -116.48%-1.26M | 192.31%6.4M | 588.64%7.61M | -39.40%-6.93M | -59.63%-1.56M | -379.84%-4.97M | -165.33%-976K | 152.81%1.78M |
| Net cash before financing | 134.14%1.69M | -275.97%-11.92M | -196.56%-4.94M | 140.81%6.78M | 158.08%5.12M | -649.98%-16.6M | -9.18%-8.82M | 119.64%3.02M | 81.76%-8.08M | -137.14%-15.37M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | 395.47%14.86M | ---- | 76.47%3M | ---- | --1.7M |
| Refund | ---- | -9.09%-1.2M | ---- | 92.08%-1.1M | ---- | -4,395.47%-13.89M | ---- | ---309K | ---- | ---- |
| Interest paid - financing | ---- | 9.96%-886K | ---- | -20.59%-984K | ---- | -24.01%-816K | ---- | 8.23%-658K | ---- | -40.31%-717K |
| Other items of the financing business | 6.91%-943K | ---- | 34.26%-1.01M | ---- | -175.18%-1.54M | ---- | -128.94%-560K | ---- | 277.20%1.94M | ---2.1M |
| Net cash from financing operations | 6.91%-943K | 1.22%-3.57M | 34.26%-1.01M | -813.64%-3.62M | -175.18%-1.54M | -235.59%-396K | -128.94%-560K | 96.01%-118K | 277.20%1.94M | -479.06%-2.96M |
| Effect of rate | -39.14%577K | 138.91%1.07M | -64.53%948K | 47.43%-2.74M | 2,800.00%2.67M | -214.12%-5.21M | 75.31%-99K | 458.08%4.56M | 74.01%-401K | -299.37%-1.27M |
| Net Cash | 112.51%745K | -590.75%-15.5M | -266.44%-5.96M | 118.58%3.16M | 138.17%3.58M | -686.00%-17M | -52.70%-9.38M | 115.82%2.9M | 86.47%-6.14M | -144.84%-18.33M |
| Begining period cash | -34.79%27.05M | 1.03%41.49M | 1.03%41.49M | -35.10%41.06M | -35.10%41.06M | 13.37%63.27M | 13.37%63.27M | -26.00%55.81M | -26.00%55.81M | 122.49%75.41M |
| Cash at the end | -22.21%28.37M | -34.79%27.05M | -22.91%36.48M | 1.03%41.49M | -12.04%47.32M | -35.10%41.06M | 9.19%53.8M | 13.37%63.27M | 72.88%49.27M | -26.00%55.81M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.